U.S. Consumer Finance Stock News

Enova International (ENVA) heads into today’s Q4 2025 earnings release with analysts expecting year over year growth in EPS and revenue, following two years of consistently topping earnings forecasts. See our latest analysis for Enova International. At a share price of $158.55, Enova International has seen a 32.92% 90 day share price return and a 44.45% 1 year total shareholder return, suggesting momentum has been building ahead of today’s earnings update and recent guidance around expected...

If you are wondering whether Home Depot is still a solid value at around US$386.53 per share, you are not alone. The stock often sits on many investors' watchlists when they think about large US retailers. The share price has returned 1.7% over the last 7 days, 10.5% over the last 30 days, 11.8% year to date, 32.8% over 3 years and 61.7% over 5 years, while the return over the last year sits at a 6.8% decline. Recent attention on Home Depot has focused on how its share price performance...

SBA Communications: Key performance snapshot SBA Communications (SBAC) has drawn investor attention after a period of mixed returns, with the stock roughly flat over the past month and weaker over the past 3 months and year. The company reports annual revenue of US$2.79b and net income of US$856.97m, with both metrics showing single digit annual growth. Recent share performance contrasts with these fundamentals and this may prompt closer review from income and infrastructure focused...

If you are wondering whether United Rentals is still good value after a strong multi year run, this article walks through what the current share price could be implying about the business. The stock last closed at US$911.16, with returns of 10.1% over the past 30 days, 19.4% over 1 year and a very large gain over 5 years. This naturally raises questions about how much upside or downside might be left. Recent moves have come alongside ongoing attention on large scale construction and...

Polaris (NYSE:PII) reported its fourth quarter and full year 2025 results, showing net losses for both periods. The company highlighted revenue growth in key product segments during the year. Quarterly adjusted earnings per share came in better than expected, despite the reported net loss. Polaris, known for off road vehicles, snowmobiles and related power sports equipment, now faces a mixed picture as it reports net losses alongside revenue growth in important product areas. For you as an...

Central Bancompany Inc., based in Jefferson City, Missouri, recently reported fourth-quarter net income of US$107.6 million, or US$0.47 per share, on revenue net of interest expense of US$272.2 million, surpassing analyst expectations. The earnings beat, particularly the stronger-than-forecast revenue net of interest expense, highlights how the bank’s core operations outperformed what the market had been anticipating. With quarterly revenue net of interest expense topping forecasts, we’ll...

Why Ventas Is Back on Investor Radars Ventas (VTR) is drawing fresh attention as its earnings growth, consistent upside surprises, steady revenue profile, and expanded free cash flow are aligned with a confirmed upward share price trend. See our latest analysis for Ventas. Despite a recent 1 month share price return decline of 4.19% and some softness over the last week, Ventas still carries an 8.89% 3 month share price gain and a 26.86% 1 year total shareholder return, which suggests momentum...

TG Therapeutics plans to present new clinical data for BRIUMVI at the upcoming ACTRIMS annual forum. The updates will cover Phase 4 real world infusion experience, pediatric trial designs, and biomarker findings in relapsing multiple sclerosis. The breadth of data is aimed at further defining BRIUMVI's clinical profile beyond previously shared information. TG Therapeutics, trading on NasdaqCM:TGTX, is drawing fresh attention with this planned data package around BRIUMVI. The stock last...

Kymera Therapeutics recently outlined its 2026 preclinical and clinical milestones, highlighting the ongoing Phase 2b BREADTH trial of KT-621 in moderate to severe eosinophilic asthma, positive past Phase 1b data in atopic dermatitis, and progress in partnered programs including an oral IRAK4 degrader with Sanofi. A particularly important element of this update is the advancement of KT-621 as a first-in-class oral STAT6 degrader targeting Type 2 inflammation, alongside collaboration...

Smithfield Foods, NasdaqGS:SFD, has agreed to acquire Nathan's Famous in a move to bring the hot dog brand fully in house. The deal is intended to eliminate licensing fees and give Smithfield direct control over Nathan's premium beef product line. The transaction expands Smithfield's protein portfolio beyond pork into branded beef offerings in the processed meat market. For you as an investor, this puts a well known branded beef business under the same roof as one of the largest pork...

In recent weeks, Vertex Pharmaceuticals has attracted a series of analyst upgrades and favorable research reports highlighting the strength of its cystic fibrosis portfolio and kidney disease pipeline, alongside prior FDA orphan drug status for povetacicept. This cluster of positive opinions underscores how regulatory advantages and a focused therapeutics portfolio can materially influence how investors view a biotech’s prospects. We’ll now examine how this wave of analyst optimism around...

Renasant (RNST) is on investors’ radar after recent share performance, with the stock showing positive returns over the past week, month and past 3 months. This has prompted a closer look at its current valuation. See our latest analysis for Renasant. At a share price of $37.27, Renasant’s recent gains, including a 90 day share price return of 6.42% and a 1 year total shareholder return of 2.14%, point to steady but measured momentum as investors reassess the bank’s risk and growth...

Cardinal Health (CAH) heads into its February 5, 2026 earnings report with investor attention focused on revised forecasts for earnings per share and revenue, as well as expectations around its Pharmaceutical and Medical segment performance. See our latest analysis for Cardinal Health. At a share price of $210.93, Cardinal Health has seen a 29.57% 90 day share price return and a 63.37% 1 year total shareholder return, suggesting momentum has been building ahead of earnings and recent analyst...

What Manchester United (MANU) shareholders may focus on now With no single headline event setting the tone, Manchester United (MANU) shares have quietly moved higher in the past month, alongside a mixed return profile over the past 3 months and year. See our latest analysis for Manchester United. At a share price of $17.64, Manchester United’s recent 11.22% 1 month share price return builds on an 11.79% year to date gain. However, the 3 year total shareholder return of 21.81% and 1 year total...

Coinbase Global was selected as a custodian for U.S. spot Bitcoin and Ethereum ETFs. The company agreed to acquire Deribit, a major crypto derivatives and options trading platform. Coinbase is working with the government of Bermuda to help launch what is described as the first fully on chain national economy. NasdaqGS:COIN is trading at $213.48, with the share price showing a 23.2% decline over the past year and a very large gain over three years. Over shorter periods, the stock is down...

If you are wondering whether Teleflex at US$104.20 is starting to look interesting on value, you are not alone. The share price has seen a 1.2% gain over the last 7 days, set against a 15.1% decline over 30 days and a 42.6% drop over the past year, which can change how the market prices both risk and opportunity. Recent coverage has focused on Teleflex as a long established medical technology company, with investors weighing its position in the healthcare sector against ongoing share price...

If you are wondering whether Ameriprise Financial at around US$500 per share still offers value or is starting to look expensive, you are not alone. The stock has had a mixed run, with a 1.7% decline over the last 7 days, a 0.3% decline over 30 days, a 1.4% gain year to date, a 9.7% decline over 1 year, and stronger returns of 52.1% over 3 years and 169.1% over 5 years. Recent headlines have focused on Ameriprise Financial's position in wealth management and financial planning, as investors...

On 26 January 2026, multiple shareholder proposals were submitted to Starbucks (NasdaqGS:SBUX). The proposals question the company’s governance practices, including board structure and voting requirements. They also address human capital topics such as gender and healthcare benefits and treatment of religious organizations in employee programs. Additional scrutiny focuses on Starbucks’ diagnostic partnerships and broader corporate policies. For you as an investor, this matters because...

Moog recently drew attention for a pattern of surpassing earnings estimates, with analysts becoming increasingly upbeat about its upcoming results. Beneath this optimism, the company’s relatively modest long-term revenue growth and rising capital intensity raise questions about the efficiency of its expansion efforts. We’ll now examine how this growing analyst optimism ahead of earnings shapes Moog’s investment narrative and risk‑reward profile. Trump's oil boom is here - pipelines are...

If you have been wondering whether Range Resources is still good value after a long run in energy markets, this article will walk through what the current price could imply about the stock. The shares most recently closed at US$36.69, with returns of 6.6% over the last 7 days, 3.9% over the last 30 days, 3.9% year to date, a 0.6% decline over 1 year and 54.0% over 3 years, which hints that expectations and perceived risk have been shifting over different time frames. Recent coverage of Range...

In recent days, Cleveland-Cliffs was downgraded from Buy to Neutral by Seaport Global Securities, even as the company announced a memorandum of understanding with South Korean steelmaker POSCO and added Edilson Camara to its Board of Directors. This combination of a more cautious analyst stance alongside a potential POSCO partnership highlights the tension between balance-sheet concerns and operational opportunities in Cleveland-Cliffs’ story. Next, we’ll examine how the analyst downgrade,...

Riverwater Partners’ Small Cap Strategy recently added NPK International (NPKI) as a new holding after highlighting its role in grid expansion, electrification projects and energy system upgrades tied to the ongoing infrastructure buildout. See our latest analysis for NPK International. The latest share price of $13.65 sits alongside a 30 day share price return of 12.62% and a year to date share price return of 12.81%. The 1 year total shareholder return of 88.28% and very large 5 year total...

What CNA Financial’s Recent Returns Signal for Investors CNA Financial (CNA) has drawn attention after its shares delivered a 1.6% move over the past day and around 1.4% over the past week, while posting a small decline over the past month. See our latest analysis for CNA Financial. At a share price of $47.02, CNA’s recent 1.6% one day and 1.4% seven day share price returns sit against a modest 30 day pullback, while its 3 year total shareholder return of 37.6% and 5 year total shareholder...

Urban Outfitters (NasdaqGS:URBN) reported record quarterly revenue, profits, and earnings per share. The company highlighted these results as its best ever financial metrics for a single quarter. Performance in the quarter compared favorably to many peers in the broader retail and apparel space. Urban Outfitters, which operates the Urban Outfitters, Anthropologie, and Free People brands, sits at the intersection of apparel, home goods, and lifestyle retail. Investors have been watching this...